United States Nano-drug Market Report 2018

February 2018 | 119 pages | ID: U8BE2BD8F4CEN
QYResearch

Abstracts

In this report, the United States Nano-drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Nano-drug in these regions, from 2013 to 2025 (forecast).

United States Nano-drug market competition by top manufacturers/players, with Nano-drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Merck
• Pfizer
• Novartis
• Abbott
• GlaxoSmithKline
• Roche
• Sanofi
• Eli Lilly
• Astrazeneca
• Johnson & Johnson
• Celgene
• Novavax
• Stryker
• Gilead Sciences
• OSI Pharmaceuticals
• Kadmon Pharmaceuticals
• Samyang Biopharm
• Mitsubishi Pharma
• Kaken Pharmaceutical
• Selecta Biosciences
• Par Pharmaceutical
• Cerulean Pharma
• Navidea Biopharmaceuticals
• Lummy

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Liposomes
• Polymeric Micelles
• Solid lipid Nanoparticles
• Microemulsion and Nanoemulsion
• Nanosuspension

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Cancer and Tumors
• Autoimmune Disorders

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Nano-drug Market Report 2018

1 NANO-DRUG OVERVIEW

1.1 Product Overview and Scope of Nano-drug
1.2 Classification of Nano-drug by Product Category
  1.2.1 United States Nano-drug Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Nano-drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Liposomes
  1.2.4 Polymeric Micelles
  1.2.5 Solid lipid Nanoparticles
  1.2.6 Microemulsion and Nanoemulsion
  1.2.7 Nanosuspension
1.3 United States Nano-drug Market by Application/End Users
  1.3.1 United States Nano-drug Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Cancer and Tumors
  1.3.3 Autoimmune Disorders
1.4 United States Nano-drug Market by Region
  1.4.1 United States Nano-drug Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Nano-drug Status and Prospect (2013-2025)
  1.4.3 Southwest Nano-drug Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Nano-drug Status and Prospect (2013-2025)
  1.4.5 New England Nano-drug Status and Prospect (2013-2025)
  1.4.6 The South Nano-drug Status and Prospect (2013-2025)
  1.4.7 The Midwest Nano-drug Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Nano-drug (2013-2025)
  1.5.1 United States Nano-drug Sales and Growth Rate (2013-2025)
  1.5.2 United States Nano-drug Revenue and Growth Rate (2013-2025)

2 UNITED STATES NANO-DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Nano-drug Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Nano-drug Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Nano-drug Average Price by Players/Suppliers (2013-2018)
2.4 United States Nano-drug Market Competitive Situation and Trends
  2.4.1 United States Nano-drug Market Concentration Rate
  2.4.2 United States Nano-drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Nano-drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES NANO-DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Nano-drug Sales and Market Share by Region (2013-2018)
3.2 United States Nano-drug Revenue and Market Share by Region (2013-2018)
3.3 United States Nano-drug Price by Region (2013-2018)

4 UNITED STATES NANO-DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Nano-drug Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Nano-drug Revenue and Market Share by Type (2013-2018)
4.3 United States Nano-drug Price by Type (2013-2018)
4.4 United States Nano-drug Sales Growth Rate by Type (2013-2018)

5 UNITED STATES NANO-DRUG SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Nano-drug Sales and Market Share by Application (2013-2018)
5.2 United States Nano-drug Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES NANO-DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Merck
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Nano-drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Merck Nano-drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Pfizer
  6.2.2 Nano-drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Pfizer Nano-drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Novartis
  6.3.2 Nano-drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Novartis Nano-drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Abbott
  6.4.2 Nano-drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Abbott Nano-drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 GlaxoSmithKline
  6.5.2 Nano-drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 GlaxoSmithKline Nano-drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Roche
  6.6.2 Nano-drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Roche Nano-drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Sanofi
  6.7.2 Nano-drug Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Sanofi Nano-drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Eli Lilly
  6.8.2 Nano-drug Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Eli Lilly Nano-drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Astrazeneca
  6.9.2 Nano-drug Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Astrazeneca Nano-drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Johnson & Johnson
  6.10.2 Nano-drug Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Johnson & Johnson Nano-drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Celgene
6.12 Novavax
6.13 Stryker
6.14 Gilead Sciences
6.15 OSI Pharmaceuticals
6.16 Kadmon Pharmaceuticals
6.17 Samyang Biopharm
6.18 Mitsubishi Pharma
6.19 Kaken Pharmaceutical
6.20 Selecta Biosciences
6.21 Par Pharmaceutical
6.22 Cerulean Pharma
6.23 Navidea Biopharmaceuticals
6.24 Lummy

7 NANO-DRUG MANUFACTURING COST ANALYSIS

7.1 Nano-drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Nano-drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Nano-drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Nano-drug Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES NANO-DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Nano-drug Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Nano-drug Sales Volume Forecast by Type (2018-2025)
11.3 United States Nano-drug Sales Volume Forecast by Application (2018-2025)
11.4 United States Nano-drug Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Nano-drug
Figure United States Nano-drug Market Size (K Doses) by Type (2013-2025)
Figure United States Nano-drug Sales Volume Market Share by Type (Product Category) in 2017
Figure Liposomes Product Picture
Figure Polymeric Micelles Product Picture
Figure Solid lipid Nanoparticles Product Picture
Figure Microemulsion and Nanoemulsion Product Picture
Figure Nanosuspension Product Picture
Figure United States Nano-drug Market Size (K Doses) by Application (2013-2025)
Figure United States Sales Market Share of Nano-drug by Application in 2017
Figure Cancer and Tumors Examples
Table Key Downstream Customer in Cancer and Tumors
Figure Autoimmune Disorders Examples
Table Key Downstream Customer in Autoimmune Disorders
Figure United States Nano-drug Market Size (Million USD) by Region (2013-2025)
Figure The West Nano-drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Nano-drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Nano-drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Nano-drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Nano-drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Nano-drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Nano-drug Sales (K Doses) and Growth Rate (2013-2025)
Figure United States Nano-drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Nano-drug Market Major Players Product Sales Volume (K Doses) (2013-2018)
Table United States Nano-drug Sales (K Doses) of Key Players/Suppliers (2013-2018)
Table United States Nano-drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Nano-drug Sales Share by Players/Suppliers
Figure 2017 United States Nano-drug Sales Share by Players/Suppliers
Figure United States Nano-drug Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Nano-drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Nano-drug Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Nano-drug Revenue Share by Players/Suppliers
Figure 2017 United States Nano-drug Revenue Share by Players/Suppliers
Table United States Market Nano-drug Average Price (USD/Dose) of Key Players/Suppliers (2013-2018)
Figure United States Market Nano-drug Average Price (USD/Dose) of Key Players/Suppliers in 2017
Figure United States Nano-drug Market Share of Top 3 Players/Suppliers
Figure United States Nano-drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Nano-drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Nano-drug Product Category
Table United States Nano-drug Sales (K Doses) by Region (2013-2018)
Table United States Nano-drug Sales Share by Region (2013-2018)
Figure United States Nano-drug Sales Share by Region (2013-2018)
Figure United States Nano-drug Sales Market Share by Region in 2017
Table United States Nano-drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Nano-drug Revenue Share by Region (2013-2018)
Figure United States Nano-drug Revenue Market Share by Region (2013-2018)
Figure United States Nano-drug Revenue Market Share by Region in 2017
Table United States Nano-drug Price (USD/Dose) by Region (2013-2018)
Table United States Nano-drug Sales (K Doses) by Type (2013-2018)
Table United States Nano-drug Sales Share by Type (2013-2018)
Figure United States Nano-drug Sales Share by Type (2013-2018)
Figure United States Nano-drug Sales Market Share by Type in 2017
Table United States Nano-drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Nano-drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Nano-drug by Type (2013-2018)
Figure Revenue Market Share of Nano-drug by Type in 2017
Table United States Nano-drug Price (USD/Dose) by Types (2013-2018)
Figure United States Nano-drug Sales Growth Rate by Type (2013-2018)
Table United States Nano-drug Sales (K Doses) by Application (2013-2018)
Table United States Nano-drug Sales Market Share by Application (2013-2018)
Figure United States Nano-drug Sales Market Share by Application (2013-2018)
Figure United States Nano-drug Sales Market Share by Application in 2017
Table United States Nano-drug Sales Growth Rate by Application (2013-2018)
Figure United States Nano-drug Sales Growth Rate by Application (2013-2018)
Table Merck Basic Information List
Table Merck Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Merck Nano-drug Sales Growth Rate (2013-2018)
Figure Merck Nano-drug Sales Market Share in United States (2013-2018)
Figure Merck Nano-drug Revenue Market Share in United States (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Pfizer Nano-drug Sales Growth Rate (2013-2018)
Figure Pfizer Nano-drug Sales Market Share in United States (2013-2018)
Figure Pfizer Nano-drug Revenue Market Share in United States (2013-2018)
Table Novartis Basic Information List
Table Novartis Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Novartis Nano-drug Sales Growth Rate (2013-2018)
Figure Novartis Nano-drug Sales Market Share in United States (2013-2018)
Figure Novartis Nano-drug Revenue Market Share in United States (2013-2018)
Table Abbott Basic Information List
Table Abbott Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Abbott Nano-drug Sales Growth Rate (2013-2018)
Figure Abbott Nano-drug Sales Market Share in United States (2013-2018)
Figure Abbott Nano-drug Revenue Market Share in United States (2013-2018)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Nano-drug Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline Nano-drug Sales Market Share in United States (2013-2018)
Figure GlaxoSmithKline Nano-drug Revenue Market Share in United States (2013-2018)
Table Roche Basic Information List
Table Roche Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Roche Nano-drug Sales Growth Rate (2013-2018)
Figure Roche Nano-drug Sales Market Share in United States (2013-2018)
Figure Roche Nano-drug Revenue Market Share in United States (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Sanofi Nano-drug Sales Growth Rate (2013-2018)
Figure Sanofi Nano-drug Sales Market Share in United States (2013-2018)
Figure Sanofi Nano-drug Revenue Market Share in United States (2013-2018)
Table Eli Lilly Basic Information List
Table Eli Lilly Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Eli Lilly Nano-drug Sales Growth Rate (2013-2018)
Figure Eli Lilly Nano-drug Sales Market Share in United States (2013-2018)
Figure Eli Lilly Nano-drug Revenue Market Share in United States (2013-2018)
Table Astrazeneca Basic Information List
Table Astrazeneca Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Astrazeneca Nano-drug Sales Growth Rate (2013-2018)
Figure Astrazeneca Nano-drug Sales Market Share in United States (2013-2018)
Figure Astrazeneca Nano-drug Revenue Market Share in United States (2013-2018)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Nano-drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Johnson & Johnson Nano-drug Sales Growth Rate (2013-2018)
Figure Johnson & Johnson Nano-drug Sales Market Share in United States (2013-2018)
Figure Johnson & Johnson Nano-drug Revenue Market Share in United States (2013-2018)
Table Celgene Basic Information List
Table Novavax Basic Information List
Table Stryker Basic Information List
Table Gilead Sciences Basic Information List
Table OSI Pharmaceuticals Basic Information List
Table Kadmon Pharmaceuticals Basic Information List
Table Samyang Biopharm Basic Information List
Table Mitsubishi Pharma Basic Information List
Table Kaken Pharmaceutical Basic Information List
Table Selecta Biosciences Basic Information List
Table Par Pharmaceutical Basic Information List
Table Cerulean Pharma Basic Information List
Table Navidea Biopharmaceuticals Basic Information List
Table Lummy Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nano-drug
Figure Manufacturing Process Analysis of Nano-drug
Figure Nano-drug Industrial Chain Analysis
Table Raw Materials Sources of Nano-drug Major Players/Suppliers in 2017
Table Major Buyers of Nano-drug
Table Distributors/Traders List
Figure United States Nano-drug Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure United States Nano-drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Nano-drug Price (USD/Dose) Trend Forecast (2018-2025)
Table United States Nano-drug Sales Volume (K Doses) Forecast by Type (2018-2025)
Figure United States Nano-drug Sales Volume (K Doses) Forecast by Type (2018-2025)
Figure United States Nano-drug Sales Volume (K Doses) Forecast by Type in 2025
Table United States Nano-drug Sales Volume (K Doses) Forecast by Application (2018-2025)
Figure United States Nano-drug Sales Volume (K Doses) Forecast by Application (2018-2025)
Figure United States Nano-drug Sales Volume (K Doses) Forecast by Application in 2025
Table United States Nano-drug Sales Volume (K Doses) Forecast by Region (2018-2025)
Table United States Nano-drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States Nano-drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States Nano-drug Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources